For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent ...

GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...

A target trial emulation study compared risk for depression among older adults with type 2 diabetes initiating treatment with ...

Drugs approved for diabetes and obesity might be useful for the treatment of cognitive and mental health disorders, according ...

For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...

Data submitted to the UK drugs regulator show a total of 82 deaths related to glucagon-like peptide-1 receptor agonists, the class of drugs used for weight loss and type 2 diabetes. Data from the ...

(res), a leading physician-developed supplement brand, announced today the launch of their latest product innovation, resM™ ...

GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...

Citing that the retinal examination (fundoscopy) shall be done periodically, the Subject Expert Committee (SEC) functional ...

“Queer Eye” star Jonathan Van Ness recently posted before-and-after photos to show off his drastic weight loss. Van Ness, 37, took to his Instagram Story Sunday to share a shirtless image of himself ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.